Dr Janet Lee Martin

Senior Research Fellow
Medicine, Northern Clinical School
Kolling Institute of Medical Research

E25 - Royal North Shore Hospital
The University of Sydney
NSW 2006 Australia

T:+61 2 9926 8486
F:+61 2 9926 8484
E:

Publications

2008 | 2007 | 2006 | 2004 | 2003

2008

  
  • Marsh, D., Trahair, T., Martin, J., Chee, W., Walker, J., Kirk, E., Baxter, R., Marshall, G. Rapamycin treatment for a child with germline PTEN mutation. Nature clinical practice. Oncology. 2008; 5:357-61. [Abstract]

2007

  
  • Martin, J., Baxter, R. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology. 2007; 148:2532-2541. [Abstract]

2006

  
  • Martin, J., Jambazov, S. Insulin-Like Growth Factor Binding Protein-3 inExtracellular Matrix Stimulates Adhesion of BreastEpithelial Cells and Activation of p44/42 Mitogen-Activated Protein Kinase. Endocrinology. 2006; 147:4400-9. [Abstract]

2004

  
  • Butt, A., Martin, J., Dickson, K., McDougall, F., Firth, S., Baxter, R. Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. The Journal of clinical endocrinology and metabolism. 2004; 89:1950-6. [Abstract]

2003

  
  • Lee, J., Weiss, J., Martin, J., Scott, C. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. International journal of cancer. Journal international du cancer. 2003; 107:564-70. [Abstract]
  • Martin, J., Weenink, S., Baxter, R. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. The Journal of biological chemistry. 2003; 278:2969-76. [Abstract]